Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Outset Medical in a report on Monday, December 29th. BTIG Research restated a “buy” rating and issued a $17.00 target price on shares of Outset Medical in a research note on Tuesday, December 16th. Get Outset Medical alerts:View Our Latest Stock Report on Outset MedicalOutset Medical Trading Up 0.8%Insider Transactions at Outset MedicalNASDAQ OM opened at $5.07 on Friday. Outset Medical Company Profile(Get Free Report)Outset Medical is a medical technology company specializing in innovations for renal care. See AlsoReceive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.